患有偏偏甲状腺症的患者扩张性心肌病:叙述性综述
Maryam Abdolmaleki1, Laya Ohadi1, Saba Maleki2
1Shahid Beheshti University of Medical Sciences Tehran Iran.
Health science reports
|January 8, 2024
概括
低甲状腺功能障碍会导致扩张性心肌病 (DCM),但及时补充和维生素D可以逆转心脏功能障碍. 患者坚持治疗是管理这种内分泌相关心脏病的关键.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 甲状腺功能低下症是一种罕见的内分泌疾病,表现为低,高和不足甲状腺激素.
- 这种情况可能导致扩张性心肌病 (DCM),其特点是心室膨胀和功能受损.
研究的目的:
- 探索下甲状腺症和DCM之间的联系.
- 为了研究对心脏功能的影响.
- 评估通过补充来扭转DCM的可能性.
主要方法:
- 使用PubMed和谷歌学者进行了全面的文献搜索.
- 包括DCM的病例报告在低副甲状腺症患者.
- 分析了心脏表现,诊断和管理的病例.
主要成果:
- 缺甲状腺症中DCM呈现出心力衰竭症状,减少喷射分数和左心室功能受损.
- 实验室发现包括低血清和高酸盐水平.
- 及时用和维生素D治疗改善了心脏功能.
结论:
- 甲状腺功能低下症引起的DCM是可逆的,可及时补充和维生素D.
- 患者遵守和定期监测对于预防心脏并发症至关重要.
- 建议在内分泌疾病患者中定期对DCM进行随访.
更多相关视频
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
3.5K
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
14.6K
相关概念视频
The Parathyroid Glands
2.1K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.1K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Decreased pulse rate
544
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
544
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
168
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
168
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
